Abstract:Abstract Background Venous thromboembolism (VTE) is an important cause of morbidity and mortality in hospitalized patients. Prophylactic antithrombotic therapy has been shown to be the most effective method to reduce the health and economic burden of an often silent disease. The American College of Chest Physicians (ACCP) has been instrumental in developing guidelines for the use of prophylactic antithrombotic therapy. However, several studies have consistently demonstrated underuse of these guidelines. One such study, conducted in 2001 at our university- affiliated hospital (Jewish General Hospital, Montreal, Canada), showed that 17.4% of all VTE cases in hospitalized patients were potentially avoidable (Arnold DM, Kahn SR, et al. Chest2001) and that this represented 2/3 of all VTE cases for which thromboprophylaxis had been indicated. Consequently, in 2005, we implemented an institution-wide thromboprophylaxis policy with the aim of improving VTE prevention. Five years after this change, we reassessed physician practice patterns at our institution with regards to application of thromboprophylaxis guidelines, and determined the avoidability of each case of VTE. Objective To identify and characterize cases of potentially avoidable VTE: cases for which thromboprophylaxis was indicated according to ACCP consensus guidelines for VTE prevention, yet was administered inadequately. Methods We conducted a retrospective cohort study, which included all patients with objectively diagnosed VTE who were admitted in 2010 to the Jewish General Hospital, a university-affiliated tertiary care institution. A standardized case-report form was used to obtain data from patient charts on patient characteristics, risk factors for VTE, risk factors for bleeding, presence of indications for thromboprophylaxis as per ACCP guidelines (e.g. surgery in last 3 months, hospitalization for pneumonia), and thromboprophylaxis regimen received. Each case was classified as avoidable (a case in which thromboprophylaxis was indicated but inadequately administered), non-avoidable (a case in which thromboprophylaxis was indicated and was correctly administered), spontaneous (a case in which a VTE occurred with no evident indications for thromboprophylaxis), and ineligible (a case in which there was either contraindication to thromboprophylaxis, or which occurred at another institution). The proportions with avoidable, non-avoidable and spontaneous VTE were compared to the results we obtained in our 2001 study. Results Of the 230 cases of VTE diagnosed in 219 patients, 55 cases were classified as avoidable (23.9%), 87 were non-avoidable (37.8%), and 74 were spontaneous (32.2%). Therefore, of the 142 (i.e. 55+87) cases for which thromboprophylaxis was indicated, 38.7% were potentially avoidable. Of the avoidable VTE cases, the majority (51.0%) were due to omission of thromboprophylaxis, with another 40.0% due to delay in initiation of thromboprophylaxis. The majority (75%) of avoidable cases occurred during general medical admissions, with a minority occurring in the context of orthopedic surgery. Common additional VTE risk factors in avoidable cases were cancer, obesity and prolonged immobility. Conclusions 1 in 4 cases of all VTE, and 1 in 2.5 cases of VTE for which thromboprophylaxis was indicated could potentially have been avoided had thromboprophylaxis been administered according to ACCP guidelines. The ratio of avoidable to non-avoidable cases (38.7%; 1 in 2.5) has significantly improved since 2001(67.7%; 2 in 3). Physician education and the adoption of an institution-wide protocolized approach to thromboprophylaxis may be largely responsible for this favorable shift. However, there has also been a significant decrease in the number of VTE cases deemed “spontaneous” from 2001 to 2010 (70.8% to 32.2%). During this time period, there were no major guideline changes in indications for VTE prophylaxis that might have led to fewer VTE being labeled spontaneous and more VTE being labeled provoked. The decrease in spontaneous cases of VTE might be ascribable to a change in patient population (e.g. increased numbers of hospitalizations for malignancy-related complications), as well as a shift towards having a lower threshold to identify patients as having risk factors for VTE (e.g. patients with pneumonia, non-fracture injuries). Disclosures: No relevant conflicts of interest to declare.

Reducing Venous Thromboembolism Risk Through a Collaborative Team Approach

Lessons from the Johns Hopkins Multi-Disciplinary Venous Thromboembolism (VTE) Prevention Collaborative

Guidelines in Practice: Prevention of Venous Thromboembolism

Increasing venous thromboembolism risk assessment through a whole hospital-based intervention: a pre-post service evaluation to demonstrate quality improvement

Improving Venous Thromboembolism Prophylaxis Through Service Integration, Policy Enhancement, and Health Informatics

Improving Value in Emergency Department Management of Deep Vein Thrombosis

Evaluation of Venous Thromboembolism Prevention Practices in US Hospitals

Implementation of the Caprini risk assessment model (RAM) in surgical patients to decrease postsurgical venous thromboembolism and enoxaparin prescription at hospital discharge

252 VTUESDAYS: A QUALITY IMPROVEMENT PROJECT TO EMBED THROMBOPROPHYLAXIS REVIEWS IN AN INTERMEDIATE CARE REHABILITATION SETTING

Determining the impact of culture on venous thromboembolism prevention in trauma patients: A Southwestern Surgical Congress Multicenter trial

Improving Compliance with a Nurse-Driven Protocol for Unfractionated Heparin Infusions in Patients with Venous Thromboembolism

Interprofessional Approach Reducing Central Venous Catheters by Expanding Peripheral Access

Shifting Paradigm In Physician Practice Patterns In The Application Of Thromboprophylaxis Guidelines: An Updated Analysis Of Venous Thromboembolism Prevention At a University-Affiliated Tertiary Care Center

Approaches for optimizing venous thromboembolism prevention in injured patients: Findings from the consensus conference to implement optimal venous thromboembolism prophylaxis in trauma

Reducing the Risk of Venous Thromboembolism Following Superficial Endovenous Treatment: A UK and Republic of Ireland Consensus Study

Improving compliance of risk assessment and nonpharmacological interventions for deep venous thrombosis prevention in a respiratory ICU: a best practice implementation project

Anticoagulation stewardship: Improving adherence to clinical guidelines and reducing overuse of venous thromboembolism prophylaxis in hospitalized medical patients

Prevention of deep vein thrombosis and pulmonary embolus

Prevention and management of venous thromboembolic disease following lower extremity total joint arthroplasty

Using a venous thromboembolism checklist significantly improves VTE prevention: a junior doctor led intervention

Research Assessment and Prevention of Venous Thromboembolism Risk Based on the Electronic Medical Record